Winship Roundup | January 31, 2022

Email is not displaying correctly? View it in your browser.

January 31, 2022

Join Winship Executive Director Suresh Ramalingam, MD, for a virtual town hall meeting on Feb. 1 from 5:15 to 6:15 p.m. Hear from members of the leadership team about Winship’s clinical and research advances and what's on the horizon for Georgia's National Cancer Institute-Designated Comprehensive Cancer Center.

Read receives R21 grant for pediatric glioblastoma study

Renee Read, PhD, has received an R21 grant from the National Institutes of Neurological Disorders and Stroke for her project, “MET kinase fusions in pediatric glioblastoma.” Having previously identified fusion mutations in the MET and ALK receptor tyrosine kinases associated with pediatric high-grade gliomas, the research team will evaluate the therapeutic efficacy of tyrosine kinase inhibitors to target these mutations.

View in NIH RePORTER

Ma receives Michelson Prize for new approach to cancer vaccine development

Rong Ma, PhD, a postdoctoral fellow in the lab of Khalid Salaita, PhD, has received a $150,000 Michelson Prize for her proposal to harness the mechanical processes of cells as a new approach in the long-running quest to develop cancer vaccines. Ma was one of three scientists selected through a rigorous global competition to receive a 2021 Michelson Prize.

Lewis and Murray named assistant directors of performance improvement

Colleen Lewis, NP, and William Murray, MBA, have been named assistant directors of performance improvement for Winship. In these new clinical leadership roles working across Winship's campuses, they will drive system-wide advances in the delivery of extraordinary patient care aligned with Emory Healthcare's EmPower initiative.

World Cancer Day nursing symposium to focus on HPV and cancer risk

Winship's World Cancer Day Symposium, “HPV and Cancer Risk,” will be held online from 1 to 2 p.m. on Feb. 4. The free oncology nursing educational event (1.0 CE credit available) will feature Winship panelists Lisa Flowers, MD, Mihir Patel, MD, Kelly Summers, MS, PA-C, Diane Ayers, RN, and Martha Ryan, NP.

Learn More

Winship hosts Facebook Live on GVHD prevention

In a Facebook Live on Jan. 27, Amelia Langston, MD, and Benjamin Watkins, MD, discussed acute graft versus host disease, a condition that can occur in some adults and children who receive stem cell or bone marrow transplants. Langston and Watkins contributed to studies of the first-ever drug to receive FDA approval to treat the disease.

Watch Video

Kalinsky discusses RxPONDER trial on PQI podcast

Kevin Kalinsky, MD, MS, discussed the RxPONDER trial and other important breast cancer advances on the Jan. 26 episode of PQI Podcast. Kalinsky was lead author of the national RxPONDER study, which found that postmenopausal women with certain types of breast cancer can forgo chemotherapy.

Learn More

Kudchadkar to participate in basal cell carcinoma course

Ragini Kudchadkar, MD, is a group leader of the continuing education course, “Modernizing Care of Patients with BCC: Changes in Management Approaches,” which begins Feb. 1. Presented online by Evolve Medical Education, this small group, self-paced learning experience offers up to 3.0 AMA PRA Category 1 credits.

NCI program director shares tips for strong grant applicants

Sergey Radaev, PhD, program director from the National Cancer Institute, will present "Applying for NIH career development awards: options, interactions with NIH staff, and tips for submitting a strong application," at the next K-Club monthly meeting on Feb. 14. Register and submit your questions in advance of the virtual discussion.

Below are four selected Winship publications out of 63 published over the past week:

Funk CR, Wang S, Chen KZ, Waller A, Sharma A, Edgar CL, Gupta VA, Chandrakasan S, Zoine JT, Fedanov A, Raikar SS, Koff JL, Flowers CR, Coma S, Pachter JA, Ravindranathan S, Spencer HT, Shanmugam M, Waller EK. PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity. Blood. 2022; 139(4):523-537. PubMed PMID: 35084470.

View in PubMed

Supapannachart KJ, Chen SC, Wang Y, Yeung H. Skin Cancer Risk Factors and Screening Among Asian American Individuals. JAMA Dermatology. 2022; PubMed PMID: 35080583.

View in PubMed

Nguyen TTA, Postlewait LM, Zhang C, Meisel JL, O'Regan R, Badve S, Kalinsky K, Li X. Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer. Breast Cancer Research and Treatment. 2022; PubMed PMID: 35084624.

View in PubMed

Yeager KA, Zahnd WE, Eberth JM, Vanderpool RC, Rohweder C, Teal R, Vu M, Stradtman L, Frost EL, Trapl E, Gonzalez SK, Vu T, Ko LK, Cole A, Farris PE, Shannon J, Askelson N, Seegmiller L, White A, Edward J, Davis M, Petermann V, Wheeler SB. Financial navigation: Staff perspectives on patients' financial burden of cancer care. Journal of Cancer Survivorship: Research and Practice. 2022; PubMed PMID: 35080699.

View in PubMed